BIOMAT Database Logo BIOMAT Database Logo

Hepatitis C virus in patients with cryoglobulinemia type II. 1990

M Pascual, and L Perrin, and E Giostra, and J A Schifferli

UI MeSH Term Description Entries
D008297 Male Males
D003449 Cryoglobulinemia A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas. Cryoglobulinemias
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006525 Hepatitis, Viral, Human INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D). Viral Hepatitis, Human,Human Viral Hepatitides,Human Viral Hepatitis,Viral Hepatitides, Human
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Pascual, and L Perrin, and E Giostra, and J A Schifferli
Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia.
January 1996, Annals of internal medicine,
M Pascual, and L Perrin, and E Giostra, and J A Schifferli
Hepatitis C virus infection in type II mixed cryoglobulinemia.
October 1993, Arthritis and rheumatism,
M Pascual, and L Perrin, and E Giostra, and J A Schifferli
Interferon toxicity in hepatitis C virus-associated type II cryoglobulinemia.
January 1998, Clinical and experimental rheumatology,
M Pascual, and L Perrin, and E Giostra, and J A Schifferli
GB virus C infection in patients with type II cryoglobulinemia.
May 1998, Annals of internal medicine,
M Pascual, and L Perrin, and E Giostra, and J A Schifferli
Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia.
November 1997, Arthritis and rheumatism,
M Pascual, and L Perrin, and E Giostra, and J A Schifferli
Interferon for hepatitis C virus-negative type II mixed cryoglobulinemia.
May 1998, The New England journal of medicine,
M Pascual, and L Perrin, and E Giostra, and J A Schifferli
Type II IgM monoclonal cryoglobulinemia and hepatitis C virus infection.
January 1991, Clinical and experimental rheumatology,
M Pascual, and L Perrin, and E Giostra, and J A Schifferli
[Glomerular lesion in patients with type II mixed cryoglobulinemia having antibodies to hepatitis C virus].
October 1995, Nihon Jinzo Gakkai shi,
M Pascual, and L Perrin, and E Giostra, and J A Schifferli
A role for hepatitis C virus infection in type II cryoglobulinemia.
November 1992, The New England journal of medicine,
M Pascual, and L Perrin, and E Giostra, and J A Schifferli
[Mixed type-II cryoglobulinemia associated with a chronic hepatitis C virus infection].
April 1993, Revista clinica espanola,
Copied contents to your clipboard!